While reporting financial results for the second quarter on Friday, life science company Meridian Bioscience, Inc. (VIVO) raised its adjusted earnings and revenue guidance for the full year 2020, despite the turmoil of the COVID-19 pandemic due to the unprecedented demand for its Life Science products.
from RTT - Earnings https://ift.tt/3fxpot2
via IFTTT
No comments:
Post a Comment